Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible infections Age: Adult |
Dose: by mouth – 400 mg Frequency: once daily Duration: 7-14 days |
|
Indication: Uncomplicated gonorrhoea Age: Adult |
Dose: by mouth – 400 mg Frequency: as a single dose |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Bacterial conjunctivitis Age: 1 year of age or older |
Dose: Ophthalmic – 1 drop Frequency: every 2 hours while awake (up to 8 times) Duration: on Day 1 Note: maximum dose: 8 drops on Day 1 |
|
Indication: Bacterial conjunctivitis Age: 1 year of age or older |
Dose: Ophthalmic – 1 drop Frequency: 2 to 4 times daily while awake Duration: on Days 2 through 7 |
Administration
- Can take with/without food
- Take with full glass water
Side Effect
- Rapid heartbeat
- mental confusion
- hallucinations
- agitation
- nightmares
- depression
- photophobia
- tendon rupture
- headache
- dizziness
- insomnia
- chills
- fever
- back pain
- abdominal pain
- constipation
- nausea
- vomiting
- diarrhoea
- inflammation of the tongue
- mouth sores
- abnormal vision
- ringing in the ears
- vaginitis
- Hyperosmolar nonketotic hyperglycaemic coma
- diabetic ketoacidosis
- hypoglycaemic coma
- convulsions and mental status changes
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Antiarrhythmic agents (amiodarone, quinidine, sotalol), Arsenic trioxide, Cisapride, Chlorpromazine, Droperidol, Mefloquine, Dolasetron, Mesoridazine, Moxifloxacin, Pimozide, Tacrolimus, Pentamidine, Thioridazine, Ziprasidone
|
Additive effect on QT interval prolongation
|
|
Antidiabetics (Metformin, Glibenclamide, Glimepiride, Sitagliptin, Pioglitazone, Rosiglitazone, Empagliflozin)
|
Increased risk of blood glucose disturbances
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Diabetes
|
Can cause blood sugar fluctuations
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.